215 related articles for article (PubMed ID: 31606385)
1. Experimental models of polycystic ovary syndrome: An update.
Divyashree S; Janhavi P; Ravindra PV; Muthukumar SP
Life Sci; 2019 Nov; 237():116911. PubMed ID: 31606385
[TBL] [Abstract][Full Text] [Related]
2. Evidence from animal models on the pathogenesis of PCOS.
Walters KA; Bertoldo MJ; Handelsman DJ
Best Pract Res Clin Endocrinol Metab; 2018 Jun; 32(3):271-281. PubMed ID: 29779581
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.
Patel S
J Steroid Biochem Mol Biol; 2018 Sep; 182():27-36. PubMed ID: 29678491
[TBL] [Abstract][Full Text] [Related]
5. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
[TBL] [Abstract][Full Text] [Related]
6. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
7. Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature.
Ryu Y; Kim SW; Kim YY; Ku SY
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163591
[TBL] [Abstract][Full Text] [Related]
8. Hormone-induced rat model of polycystic ovary syndrome: A systematic review.
Noroozzadeh M; Behboudi-Gandevani S; Zadeh-Vakili A; Ramezani Tehrani F
Life Sci; 2017 Dec; 191():259-272. PubMed ID: 29055801
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome--searching for an animal model.
Szukiewicz D; Uilenbroek JT
J Med; 1998; 29(5-6):259-75. PubMed ID: 10503163
[TBL] [Abstract][Full Text] [Related]
10. The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review.
Merlo E; Silva IV; Cardoso RC; Graceli JB
J Toxicol Environ Health B Crit Rev; 2018; 21(3):181-206. PubMed ID: 30015594
[TBL] [Abstract][Full Text] [Related]
11. Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome.
Corrie L; Gulati M; Singh SK; Kapoor B; Khursheed R; Awasthi A; Vishwas S; Chellappan DK; Gupta G; Jha NK; Anand K; Dua K
Life Sci; 2021 Sep; 280():119753. PubMed ID: 34171379
[TBL] [Abstract][Full Text] [Related]
12. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
13. Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.
Puttabyatappa M; Cardoso RC; Padmanabhan V
Mol Cell Endocrinol; 2016 Nov; 435():29-39. PubMed ID: 26639019
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of intergenerational transmission of polycystic ovary syndrome.
Dumesic DA; Hoyos LR; Chazenbalk GD; Naik R; Padmanabhan V; Abbott DH
Reproduction; 2020 Jan; 159(1):R1-R13. PubMed ID: 31376813
[TBL] [Abstract][Full Text] [Related]
16. Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.
Stener-Victorin E; Padmanabhan V; Walters KA; Campbell RE; Benrick A; Giacobini P; Dumesic DA; Abbott DH
Endocr Rev; 2020 Jul; 41(4):. PubMed ID: 32310267
[TBL] [Abstract][Full Text] [Related]
17. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.
Wang J; Wu D; Guo H; Li M
Life Sci; 2019 Nov; 236():116940. PubMed ID: 31604107
[TBL] [Abstract][Full Text] [Related]
18. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
19. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.
Xita N; Tsatsoulis A
J Clin Endocrinol Metab; 2006 May; 91(5):1660-6. PubMed ID: 16522691
[TBL] [Abstract][Full Text] [Related]
20. Androgens in polycystic ovary syndrome: lessons from experimental models.
Walters KA
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):257-63. PubMed ID: 26866639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
